例如，即使薄膜被设计为旨在保护细胞不受免疫系统误伤，病人可能仍需要免疫抑制药物。
For example, while the membrane is designed to protect the cells, patients may still require immunosuppressive drugs.
应用这些抑制药物，加上其它的一些疗法，可能会改善由这种类型细胞产生的乳腺癌的预后。
Such inhibitors, in combination with other therapies, may improve the prognosis in breast cancers fueled by these cells.
雷帕霉素是一种高效低毒的大环内酯类免疫抑制药，它在细胞外的受体为FK50 6结合蛋白fkbp - 12。
Rapamycin is a macrolide with strong immunosuppressive activity and lower toxicity. Its intracellular receptor is the FK506 binding protein (FKBP-12).
应用推荐